Abstract

Previously, we demonstrated that γ-ionizing radiation (IR) triggers the invasion/migration of A549 cells via activation of an EGFR–p38/ERK–STAT3/CREB-1–EMT pathway. Here, we have demonstrated the involvement of a novel intracellular signaling mechanism in γ-ionizing radiation (IR)-induced migration/invasion. Expression of receptor-interacting protein (RIP) 1 was initially increased upon exposure of A549, a non-small cell lung cancer (NSCLC) cell line, to IR. IR-induced RIP1 is located downstream of EGFR and involved in the expression/activity of matrix metalloproteases (MMP-2 and MMP-9) and vimentin, suggesting a role in epithelial-mesenchymal transition (EMT). Our experiments showed that IR-induced RIP1 sequentially induces Src-STAT3-EMT to promote invasion/migration. Inhibition of RIP1 kinase activity and expression blocked induction of EMT by IR and suppressed the levels and activities of MMP-2, MMP-9 and vimentin. IR-induced RIP1 activation was additionally associated with stimulation of the transcriptional factor NF-κB. Specifically, exposure to IR triggered NF-κB activation and inhibition of NF-κB suppressed IR-induced RIP1 expression, followed by a decrease in invasion/migration as well as EMT. Based on the collective results, we propose that IR concomitantly activates EGFR and NF-κB and subsequently triggers the RIP1–Src/STAT3–EMT pathway, ultimately promoting metastasis.

Highlights

  • Lung cancer is one of the most prevalent cancer types worldwide

  • We showed that ionizing radiation (IR) (10 Gy) treatment enhances the invasion/migration of A549 cells [17]

  • IR treatment clearly led to an increase in MMP-2, MMP-9 and vimentin levels (Figure 1D)

Read more

Summary

Introduction

Lung cancer is one of the most prevalent cancer types worldwide. Non-small cell lung cancer (NSCLC) represents the majority of cases, accounting for 85% of all lung cancers. Radiotherapy is the principal treatment method applied to induce cell death for various cancer types. This option is associated with several side-effects, including decreased immunity owing to destruction of immune cells, resulting in reduced elimination by the immune system and subsequent resistance to therapy [5]. Besides having a therapeutic effect, radiotherapy can promote the malignant characteristics of cancer cells [6]. This IR-induced development of radiation resistance of cancer cells has contributed significantly to high mortality rates in patients. The molecular mechanisms of action of these factors in NSCLC are yet to be elucidated

Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.